Cargando…
Hydrogen Sulfide as a Potential Therapy for Heart Failure—Past, Present, and Future
Hydrogen sulfide (H(2)S) is an endogenous, gaseous signaling molecule that plays a critical role in cardiac and vascular biology. H(2)S regulates vascular tone and oxidant defenses and exerts cytoprotective effects in the heart and circulation. Recent studies indicate that H(2)S modulates various co...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003444/ https://www.ncbi.nlm.nih.gov/pubmed/33808673 http://dx.doi.org/10.3390/antiox10030485 |
_version_ | 1783671691362172928 |
---|---|
author | LaPenna, Kyle B. Polhemus, David J. Doiron, Jake E. Hidalgo, Hunter A. Li, Zhen Lefer, David J. |
author_facet | LaPenna, Kyle B. Polhemus, David J. Doiron, Jake E. Hidalgo, Hunter A. Li, Zhen Lefer, David J. |
author_sort | LaPenna, Kyle B. |
collection | PubMed |
description | Hydrogen sulfide (H(2)S) is an endogenous, gaseous signaling molecule that plays a critical role in cardiac and vascular biology. H(2)S regulates vascular tone and oxidant defenses and exerts cytoprotective effects in the heart and circulation. Recent studies indicate that H(2)S modulates various components of metabolic syndrome, including obesity and glucose metabolism. This review will discuss studies exhibiting H(2)S -derived cardioprotective signaling in heart failure with reduced ejection fraction (HFrEF). We will also discuss the role of H(2)S in metabolic syndrome and heart failure with preserved ejection fraction (HFpEF). |
format | Online Article Text |
id | pubmed-8003444 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-80034442021-03-28 Hydrogen Sulfide as a Potential Therapy for Heart Failure—Past, Present, and Future LaPenna, Kyle B. Polhemus, David J. Doiron, Jake E. Hidalgo, Hunter A. Li, Zhen Lefer, David J. Antioxidants (Basel) Review Hydrogen sulfide (H(2)S) is an endogenous, gaseous signaling molecule that plays a critical role in cardiac and vascular biology. H(2)S regulates vascular tone and oxidant defenses and exerts cytoprotective effects in the heart and circulation. Recent studies indicate that H(2)S modulates various components of metabolic syndrome, including obesity and glucose metabolism. This review will discuss studies exhibiting H(2)S -derived cardioprotective signaling in heart failure with reduced ejection fraction (HFrEF). We will also discuss the role of H(2)S in metabolic syndrome and heart failure with preserved ejection fraction (HFpEF). MDPI 2021-03-19 /pmc/articles/PMC8003444/ /pubmed/33808673 http://dx.doi.org/10.3390/antiox10030485 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ). |
spellingShingle | Review LaPenna, Kyle B. Polhemus, David J. Doiron, Jake E. Hidalgo, Hunter A. Li, Zhen Lefer, David J. Hydrogen Sulfide as a Potential Therapy for Heart Failure—Past, Present, and Future |
title | Hydrogen Sulfide as a Potential Therapy for Heart Failure—Past, Present, and Future |
title_full | Hydrogen Sulfide as a Potential Therapy for Heart Failure—Past, Present, and Future |
title_fullStr | Hydrogen Sulfide as a Potential Therapy for Heart Failure—Past, Present, and Future |
title_full_unstemmed | Hydrogen Sulfide as a Potential Therapy for Heart Failure—Past, Present, and Future |
title_short | Hydrogen Sulfide as a Potential Therapy for Heart Failure—Past, Present, and Future |
title_sort | hydrogen sulfide as a potential therapy for heart failure—past, present, and future |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003444/ https://www.ncbi.nlm.nih.gov/pubmed/33808673 http://dx.doi.org/10.3390/antiox10030485 |
work_keys_str_mv | AT lapennakyleb hydrogensulfideasapotentialtherapyforheartfailurepastpresentandfuture AT polhemusdavidj hydrogensulfideasapotentialtherapyforheartfailurepastpresentandfuture AT doironjakee hydrogensulfideasapotentialtherapyforheartfailurepastpresentandfuture AT hidalgohuntera hydrogensulfideasapotentialtherapyforheartfailurepastpresentandfuture AT lizhen hydrogensulfideasapotentialtherapyforheartfailurepastpresentandfuture AT leferdavidj hydrogensulfideasapotentialtherapyforheartfailurepastpresentandfuture |